23andMe to slash 40% of its workforce, end therapeutics program to cut costs

• 

  23andMe cuts 40% of its workforce and discontinues therapeutics division

  Health - ABC News - Yesterday
• 

  Genetic testing firm 23andMe cuts 40% of its workforce amid financial struggles

  World - The Guardian - Yesterday
• 

  23andMe Lays Off 40 Percent of its Staff, Ends All Therapy Programs

  Business - Inc. - Yesterday

• 23andMe to lay off 40% of its workforce as stock price plummets

  Top stories - CBS News - Yesterday

• 23andMe reports sales decline a day after announcing plans to cut 40% of workforce

  Business - CNBC - Yesterday

• Sage Therapeutics’ stock falls 4.7% as biotech unveils plan to cut 33% of workforce

  Business - MarketWatch - October 17
• 

  DNA-testing site 23andMe to lay off 40% of its workers

  Top stories - BBC News - Yesterday

More from MarketWatch

• Cisco sees product orders accelerate in the AI era, and its outlook moves higher

  Business - MarketWatch - 1 hour ago

• Dow shrugs off new inflation data. Bond yields suggest it’s ‘top of mind’ for 2025.

  Business - MarketWatch - 1 hour ago

• Why one economist says Elon Musk could hold the key to lower mortgage rates

  Business - MarketWatch - 2 hours ago

• The ‘Trump bump’ added $75,000 to my $1.3 million portfolio. I’m 39. Should I retire early and move to Europe?

  Business - MarketWatch - 2 hours ago

• ‘I’m young, debt-free and happy-go-lucky’: My boyfriend has $45,000 in debts, two houses, two kids and pays child support. Is he a safe bet to marry?

  Business - MarketWatch - 2 hours ago